Formulations of Enzalutamide

Number of patents in Portfolio can not be more than 2000

United States of America

APP PUB NO 20250049721A1
SERIAL NO

18931464

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

This disclosure provides formulations of enzalutamide and their use for treating hyperproliferative disorders.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
ASTELLAS PHARMA INC5-1 NIHONBASHI-HONCHO 2 -CHOME CHUO-KU TOKYO 103-8411 ?103-8411

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Everett, Jason A Bend, US 13 38
Irie, Ryousuke Tokyo, JP 11 19
Kanbayashi, Atsushi Tokyo, JP 12 22
Konagurthu, Sanjay Bend, US 18 30
Lorenz, Douglas Alan Bend, US 21 72
Matz, Sheila North Conway, US 11 19
Nishimura, Koji Tokyo, JP 77 399
Oba, Shinsuke Tokyo, JP 15 25
Sakai, Toshiro Tokyo, JP 27 46
Takaishi, Yuuki Tokyo, JP 29 237
Toyota, Hiroyasu Tokyo, JP 13 21
Wald, Randy J Bend, US 16 125

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation